Short answer
PRO DEX INC (PDEX) filed its Q3 2026 10-Q quarterly report on Oct 29, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $21M (up 11.0% year over year) with net income of $3M.
Q3 2026 key financials · XBRL
- Revenue
- $21M
- +11.0% YoY
- Net income
- $3M
- −34.9% YoY
- Operating margin
- 17.1%
- Gross margin
- 33.4%
- EPS (diluted)
- $0.92
- −34.3% YoY
Source: XBRL data from the PRO DEX INC (PDEX) Q3 2026 10-Q on SEC EDGAR. USD.
PRO DEX INC Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $20.6M, up 11% YoY from $18.5M, led by medical devices at $17.4M
- Gross margin 33% vs 29% YoY, with gross profit $6.9M vs $5.4M
- Orthopedic sales $12.8M, up 16%; repair revenue $2.1M, down 44%
- Cash $11.8M vs $8.2M, operating cash flow $6.5M vs $2.3M
- Backlog $43.1M, supplier shipment delays risk handpiece deliveries; $11M revolving capacity available
Risk Factors
- No material changes to risk factors from the June 30, 2026 Form 10-K
- Carried-forward business risk: factors may adversely affect future financial condition and results
- Carried-forward disclosure risk: additional uncertainties appear in financial statement notes and MD&A
- Carried-forward completeness risk: disclosed risks may not include all future business uncertainties
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other PRO DEX INC quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.